Hasta La Gadget!

A new therapy for treatment-resistant depression has received a milestone Breakthrough Therapy designation from the Food and Drug Administration (FDA). The new designation is notable for one important reason: the treatment involves psilocybin, the active ingredient found in a variety of mushrooms collectively known as “magic mushrooms.” Psilocybin, as with most other psychedelics, is a scheduled drug in the United … Continue reading